The Unprecedented Nature of COVID-19 Vaccine Development & Distribution



The COVID-19 pandemic remains the number one health concern around the globe as we await approval of multiple vaccines. There are still many unanswered questions and challenges that lie ahead for the biopharma industry, health stakeholders, and government, particularly around development, prioritization, and distribution of the vaccines. Podcast host Bob Coughlin and his guests, Clement Lewin, Head of BARDA Office & New Vaccines at Sanofi Pasteur, and Dr. Kelly Moore, Associate Director of the Immunization Action Coalition & Adjunct Associate Professor at Vanderbilt University Medical Center, discuss these timely issues. To learn more, go to MassBio.org.


Leave a Reply

*